<div id="readability-page-1"><p>Uranium Royalty (NASDAQ:UROY - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.01), Zacks reports. Uranium Royalty had a negative return on equity of 0.56% and a negative net margin of 2.90%.</p><div><p><span></span><span>Get <strong>Uranium Royalty</strong> alerts:</span></p></div><h2>Uranium Royalty Stock Performance</h2><ul><li>2 Uranium Stocks Fueling Growth From the Nuclear Power Surge</li></ul><p>NASDAQ:UROY traded up $0.18 during trading hours on Thursday, reaching $3.87. The stock had a trading volume of 1,503,645 shares, compared to its average volume of 3,317,984. The stock has a market cap of $540.65 million, a P/E ratio of -387.00 and a beta of 1.43. The stock has a 50 day simple moving average of $3.97 and a 200 day simple moving average of $3.24. Uranium Royalty has a 12-month low of $1.43 and a 12-month high of $5.37. </p><h2>Institutional Investors Weigh In On Uranium Royalty</h2><p>Several large investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. increased its position in shares of  Uranium Royalty by 25.4% during the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company's stock valued at $183,000 after buying an additional 21,118 shares during the period.  Thompson Davis &amp; CO. Inc. purchased a new position in  Uranium Royalty during the second quarter valued at approximately $33,000.  Vident Advisory LLC increased its holdings in  Uranium Royalty by 47.1% during the 2nd quarter. Vident Advisory LLC now owns 1,480,151 shares of the company's stock worth $3,700,000 after acquiring an additional 474,030 shares during the period.  Corient Private Wealth LLC purchased a new stake in  Uranium Royalty in the 2nd quarter worth approximately $29,000.  Finally, BNP Paribas Financial Markets bought a new position in  Uranium Royalty in the 3rd quarter valued at $128,000. Hedge funds and other institutional investors own  24.19% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of equities analysts have recently weighed in on the company. Zacks Research downgraded Uranium Royalty from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, November 26th. Wall Street Zen upgraded Uranium Royalty from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, September 13th. Weiss Ratings  reissued a &#34;sell (d+)&#34; rating on shares of Uranium Royalty in a research report on Wednesday, October 8th. Finally, Raymond James Financial  restated a &#34;market perform&#34; rating on shares of Uranium Royalty in a research note on Tuesday, September 23rd. One analyst  has rated the stock with a Buy rating, three have assigned  a Hold rating and one  has assigned  a Sell rating to the company's stock. According to data from MarketBeat.com, the company  has an average rating of &#34;Hold&#34; and a consensus target price of $4.50.</p><p><b>Check Out Our Latest Report on Uranium Royalty</b></p><h2>Uranium Royalty Company Profile</h2> (Get Free Report)<p>Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. The company has royalty interests in the McArthur River, Cigar Lake / Waterbury Lake, Roughrider, Russell Lake, Russell Lake south, and Dawn Lake projects in Saskatchewan, Canada; Anderson and San Rafael projects in Arizona; Lance and Reno Creek projects in Wyoming; Church Rock and Roca Honda projects in New Mexico; Dewey-Burdock project in South Dakota; Slick Rock project in Colorado; Langer Heinrich project in Namibia; and Michelin project in Newfoundland and Labrador, Canada; Energy Queen and Whirlwind project in Utah; and Workman Creek projects in Arizona.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Uranium Royalty</li><li>Health Care Stocks Explained: Why You Might Want to Invest</li><li>Oracle Stock Hit Hard: Why Its AI Pipeline Could Drive a 2026 Rally</li><li>How to Profit From Growth Investing </li><li>Beyond the Magnificent 7: Meet 3 of Tech’s Rising Stars</li><li>Trading Stocks: RSI and Why it's Useful</li><li>The Quantum Fleet: Investing in the New Quantum Standard</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVJPWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VVJPWQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Uranium Royalty Right Now?</h2><p>Before you consider Uranium Royalty, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uranium Royalty wasn't on the list.</p><p>While Uranium Royalty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

UROY

<p>Uranium Royalty (NASDAQ:UROY) reported a quarterly earnings per share of ($0.02), missing analysts' estimates of ($0.01). The company had a negative net margin of 2.90% and a negative return on equity of 0.56%. The stock traded up $0.18 to $3.87 with a market cap of $540.65 million. Institutional investors hold 24.19% of the stock. Analysts have given the stock an average rating of "Hold" with a consensus target price of $4.50.</p>

Uranium Royalty (NASDAQ:UROY) Issues Earnings Results